# Erlotinib Hcl (Erlotinib)

Source: https://ourhealthnetwork.com/drugs/erlotinib-hcl
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Erlotinib Hcl?

Erlotinib Hcl (brand name: Erlotinib) is a kinase inhibitor. It is prescribed to treat carcinoma, non-small-cell lung.

## Brand names

Erlotinib

## Indications

Erlotinib Hcl is prescribed for the treatment of carcinoma and non-small-cell lung.

## Conditions treated

- [Carcinoma](https://ourhealthnetwork.com/conditions/carcinoma)
- [Non-Small-Cell Lung](https://ourhealthnetwork.com/conditions/non-small-cell-lung)

## Mechanism of action

Epidermal growth factor receptor (EGFR) is expressed on the cell surface of both normal and cancer cells. In some tumor cells signaling through this receptor plays a role in tumor cell survival and proliferation irrespective of EGFR mutation status.

## Drug classification

- Established Pharmacologic Class: kinase inhibitors
- Route of administration: ORAL

## Common side effects

and asthenia, cation were rash, diarrhea

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)